40,687
Views
146
CrossRef citations to date
0
Altmetric
Review Article

Chronic gastritis

&
Pages 657-667 | Received 28 Jan 2015, Accepted 12 Feb 2015, Published online: 22 Apr 2015

References

  • IARC. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1–241.
  • RSchindler. Chronic gastritis. Klin Wochenschr 1966;44:601–12.
  • MSiurala. The story of gastritis. Scand J Gastroenterol Suppl 1991;186:1–3.
  • ATelaranta-Keerie, RKara, LPaloheimo, MHärkönen, PSipponen. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints. Scand J Gastroenterol 2010;45:1036–41.
  • ABPrice. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6:209–22.
  • MFDixon, RMGenta, JHYardley, PCorrea. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996. 20:1161–81.
  • PCorrea. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988;83:504–9.
  • BJMarshall, JRWarren. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;323:1311–15.
  • KVaris. Family of behavior of chronic gastritis. Ann Clin Res 1981;13:123–9.
  • JValle, KSeppälä, PSipponen, TKosunen. Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol 1991;26:1057–65.
  • MHojo, HMiwa, TOhkusa, ROhkura, AKurosawa, NSato. Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16:1923–32.
  • BAnnibale, EDi Giulio, PCaruana, ELahner, GCapurso, CBordi, et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment Pharmacol Ther 2002;16:1723–31.
  • PEArkkila, KSeppälä, MAFärkkilä, LVeijola, PSipponen. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study. Scand J Gastroenterol 2006;41:782–90.
  • MSiurala, KVaris, MWiljasalo. Studies of patients with atrophic gastritis: a 10–15-year follow-up. Scand J Gastroenterol 1966;1:40–8.
  • KVillako, MKekki, ATamm, RTammur, ESavisaar, VViirsalu, et al. Epidemiology and dynamics of gastritis in a representative sample of an Estonian urban population. Scand J Gastroenterol 1982;17:601–7.
  • TIhamäki, MKekki, PSipponen, MSiurala. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol 1985;20:485–91.
  • HIMaaroos, KPVillako, PSipponen, MKekki, MSiurala, RTammur, et al. Helicobacter pylori and chronic gastritis in the gastric biopsy material in a group of randomly selected adult inhabitants of Estonia. Arkh Patol 1990;52:9–11.
  • MKekki, HIMaaroos, PSipponen, RUibo, RTammur, ATamm, et al. Grade of Helicobacter pylori colonization in relation to gastritis: a six-year population-based follow-up study. Scand J Gastroenterol Suppl 1991;186:142–50.
  • KVillako, MKekki, HIMaaroos, PSipponen, RUibo, RTammur, et al. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol Suppl 1991;186:135–41.
  • JValle, MKekki, PSipponen, TIhamäki, MSiurala. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996;31:546–50.
  • KVillako, MKekki, HIMaaroos, PSipponen, RTammur, ATamm, et al. A 12-year follow-up study of chronic gastritis and Helicobacter pylori in a population-based random sample. Scand J Gastroenterol 1995;30:964–7.
  • HIMaaroos, TVorobjova, PSipponen, RTammur, RUibo, TWadström, et al. An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis. Scand J Gastroenterol 1999;34:864–9.
  • MSiurala, PSipponen, MKekki. Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol Suppl 1985;109:69–76.
  • PSipponen, MKekki, MSiurala. The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991;6:244–51.
  • HIMaaroos, TRägo, PSipponen, MSiurala. Helicobacter pylori and gastritis in children with abdominal complaints. Scand J Gastroenterol 1991;26:95–9.
  • HIMaaroos, MKekki, KVillako, PSipponen, ATamm, LSadeniemi. The occurrence and extent of Helicobacter pylori colonization and antral and body gastritis profiles in an Estonian population sample. Scand J Gastroenterol 1990;25:1010–17.
  • MKekki, MSiurala, KVaris, PSipponen, PSistonen, HRNevanlinna. Classification principles and genetics of chronic gastritis. Scand J Gastroenterol Suppl 1987;141:1–28.
  • TIhamäki, PSipponen, KVaris, MKekki, MSiurala. Characteristics of gastric mucosa which precede occurrence of gastric malignancy: results of long-term follow-up of three family samples. Scand J Gastroenterol Suppl 1991;186:16–23.
  • HIMaaroos, MKekki, KVillako, PSipponen, ATamm, LSadeniemi. The occurrence and extent of Helicobacter pylori colonization and antral and body gastritis profiles in an Estonian population sample. Scand J Gastroenterol 1990;25:1010–17.
  • HRautelin, PSipponen, KSeppälä, SSarna, DDanielsson, TUKosunen. Gastric inflammation and neutrophil-activating and cytotoxin-producing Helicobacter pylori strains. Scand J Gastroenterol 1996;31:639–42.
  • MKekki, MSiurala, TIhamäki. Enrichment of combined antral and corpus atrophic gastritis ("combined AG") in sibs of gastric carcinoma patients. Scand J Gastroenterol Suppl 1991;186:24–8.
  • KVaris. Epidemiology of gastritis. Scand J Gastroenterol Suppl 1982;79:44–51.
  • PSipponen, JValle, KVaris, MKekki, TIhamäki, MSiurala. Fasting levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990;25:513–19.
  • PSipponen, MKekki, KSeppälä, MSiurala. The relationships between chronic gastritis and gastric acid secretion. Aliment Pharmacol Ther 1996;10:103–18.
  • MKekki, TIhamäki, KVaris, MSiurala. Chronic gastritis profiles in sibs of probands calculated to carry a highly increased risk of gastric carcinoma. Scand J Gastroenterol Suppl 1991;186:29–32.
  • AKokkola, TUKosunen, PPuolakkainen, PSipponen, MHärkönen, FLaxen, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003;111:619–24.
  • PSipponen, MKekki, MSiurala. Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer 1984;49:521–30.
  • PSipponen, MKekki, MSiurala. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer 1983;52:1062–8.
  • PCorrea, MBPiazuelo. The gastric precancerous cascade. J Dig Dis 2012;13:2–9.
  • WCYou, JYLi, WJBlot, YSChang, MLJin, MHGail, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999;83:615–19.
  • PCorrea, WHaenszel, CCuello, DZavala, EFontham, GZarama, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990;50:4737–40.
  • PSipponen, THelske, PJärvinen, HHyvärinen, KSeppälä, MSiurala. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut 1994;35:1167–71.
  • PSipponen. Helicobacter pylori gastritis–epidemiology. J Gastroenterol 1997;32:273–7.
  • MOona, MUtt, INilsson, OUibo, TVorobjova, HIMaaroos. Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-years period of profound socioeconomic changes. Helicobacter 2004;9:223–41.
  • LHEusebi, RMZagari, FBazzoli. Epidemiology of Helicobacter pylori infection. Helicobacter 2014;19:1–5.
  • ATAxon. Review article: is Helicobacter pylori transmitted by the gastro-oral route? Aliment Pharmacol Ther 1995;9:585–8.
  • KVaris, UHStenman, JLehtola, MSiurala. Gastric lesion and pernicious anemia: a family study. Acta Hepatogastroenterol (Stuttg) 1978;25:62–7.
  • KVaris, MIsokoski. Screening of type A gastritis. Ann Clin Res 1981;13:133–8.
  • MKekki, KVaris, HPohjanpalo, MIsokoski, TIhamäki, MSiurala. Course of antrum and body gastritis in pernicious anemia families. Dig Dis Sci 1983;28:698–704.
  • TVorobjova, GFaller, HIMaaroos, PSipponen, KVillako, RUibo, et al. Significant increase in antigastric autoantibodies in a long-term follow-up study of H.pylori gastritis. Virchows Arch 2000;437:37–45.
  • RUibo, TVorobjova, KMetsküla, KKisand, TWadström, TKivik. Association of Helicobacter pylori and gastric autoimmunity: a population-based study. FEMS Immunol Med Microbiol 1995;11:65–8.
  • TVorobjova, HIMaaroos, Uibo Immune response to Helicobacter pylori and its association with the dynamics of chronic gastritis in the antrum and corpus. APMIS 2008;116:465–76.
  • ETahara. Genetic pathways of two types of gastric cancer. IARC Sci Publ 2004;157:327–49.
  • YQu, SDang, PHou. Gene methylation in gastric cancer. Clin Chim Acta 2013;424:56–65.
  • PSipponen, FLaxén, KHuotari, MHärkönen. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 2003;38:1209–16.
  • CBolander-Gouaille. Focus on homocysteine and the vitamins involved in its metabolism. France: Springer-Verlag; 2002. ISBN 2-287-59712-3.
  • PSipponen, MHärkönen. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol 2010;45:133–8.
  • MPSalaspuro. Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci 2003;40:183–208.
  • MSalaspuro. Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers. Scand J Gastroenterol 2009;44:912–25.
  • PSipponen. Chronic gastritis and ulcer risk. Scand J Gastroenterol 1990;25:193–6.
  • PSipponen, KSeppälä, MÄärynen, THelske, PKettunen. Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut 1989;30:922–9.
  • MKekki, PSipponen, MSiurala, WLaszewicz. Peptic ulcer and chronic gastritis: their relation to age and sex, and to location of ulcer and gastritis. Gastroenterol Clin Biol 1990;14:217–23.
  • PSipponen, KVaris, OFräki, UMKorri, KSeppälä, MSiurala. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990;25:966–7.
  • PEArkkila, KSeppälä, TUKosunen, RHaapiainen, EKivilaakso, PSipponen, et al. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Am J Gastroenterol 2003;98:2149–56.
  • ATAxon. Helicobacter pylori therapy: effect on peptic ulcer disease. J Gastroenterol Hepatol 1991;6:131–7.
  • TUKosunen, EPukkala, SSarna, KSeppälä, AAromaa, PKnekt, et al. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study. Int J Cancer 2011;128:433–9.
  • Y-CLee, TH-HChen, H-MChiu, CTShun, HChiang, TYLiu, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 2013;62:676–82.
  • HIMaaroos, MKekki, TVorobjova, VSalupere, PSipponen. Risk of recurrence of gastric ulcer, chronic gastritis, and grade of Helicobacter pylori colonization. Scand J Gastroenterol 1994;29:532–6.
  • PSipponen, MKekki, JHaapakoski, TIhamäki, MSiurala. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173–7.
  • PSipponen, TUKosunen, JValle, MRiihelä, KSeppälä. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992;45:319–23.
  • KVaris, PRTaylor, PSipponen, IMSamloff, OPHeinonen, DAlbanes, et al. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol 1998;33:294–300.
  • LAgréus, EJKuipers, LKupcinskas, PMalfertheiner, FDi Mario, MLeja, et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012;47:136–47.
  • Fdi Mario, LGCavallaro. Non-invasive tests in gastric diseases. Dig Liver Dis 2008;40:523–30.
  • MDinis-Ribeiro, Ada Costa-Pereira, CLopes, JBarbosa, MGuilherme, LMoreira-Dias, et al. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 2004;6:449–56.
  • KVaris, MKekki, MHärkönen, PSipponen, IMSamloff. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol Suppl 1991;186:117–23.
  • MKekki, IMSamloff, KVaris, TIhamäki. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl 1991;186:109–16.
  • PSipponen, MHärkönen, AAlanko, OSuovaniemi. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002;48:505–15.
  • PSipponen, MStolte. Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 1997;29:671–8.
  • MRugge, AMeggio, GPennelli, FPiscioli, LGiacomelli, GDe Pretis, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007;56:631–6.
  • PSipponen, DYGraham. Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol 2007;42:2–10.
  • IMSamloff. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982;82:26–33.
  • OSuovaniemi. Automated Instrumentation for Clinical and Research Laboratories. Innovations and development of vertical light beam photometers and electronic pipettes. University of Helsinki 1994; Academic dissertation. ISBN 952-90-5248-0.
  • Available from www.biohithealthcare.com/about-us/history.
  • KMiki. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - “ABC method”. Proc Jpn Acad Ser B Phys Biol Sci 2011;87:405–14.